Showing results (671-680 of 4,466) with videos related to
Sort By:
Pageof 447
Japanese Circulation Journal|October 1, 1985
Percutaneous transluminal coronary angioplasty for multiple lesions in a coronary artery--report of two casesT Kobayashi, T Yoshino, T Oda, et al.European Journal of Nuclear Medicine|January 1, 1988
Unusual bone scintigraphy in chronic myelogenous leukemia--report of a case showing extensive uptake defectY Ishino, C Nakayama, H Shiozaki, et al.Clinical Nutrition ESPEN|April 1, 2017
An empirically derived dietary pattern associated with breast cancer risk is validated in a nested case-control cohort from a randomized primary prevention trialBrandon H Hidaka, Bruce F Kimler, Carol J Fabian, et al.The Journal of Laryngology and Otology|May 2, 2000
A case of extramedullary plasmacytoma arising from the nasal septumH Hidaka, K Ikeda, T Oshima, et al.Hearing Research|April 5, 2000
Effects of contralateral noise on measurement of the psychophysical tuning curveT Kawase, M Ogura, H Hidaka, et al.The Journal of Biological Chemistry|March 15, 1990
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase IIH Tokumitsu, T Chijiwa, M Hagiwara, et al.Biochemical and Biophysical Research Communications|June 30, 1987
Induction by fibroblast growth factor of angiotensin converting enzyme in vascular endothelial cells in vitroT Okabe, K Yamagata, M Fujisawa, et al.Cancer Letters|August 31, 1993
Reverse relationship between malignancy and cyclic AMP-dependent protein kinase activity in Yoshida rat ascites hepatomasK Miyamoto, S Nakamura, M Nomura, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1978
A novel vascular relaxing agent, N-(6--aminohexyl)-5-chloro-1-naphthalensulfonamide which affects vascular smooth muscle actomyosinH Hidaka, M Asano, S Iwadare, et al.Biochemical Pharmacology|September 23, 1998
Unique inhibitory action of the synthetic compound 2-[N-(2-aminoethyl)-N-(5-isoquinolinesulfonyl)] amino-N-(4-chlorocinnamyl)-N-methylbenzylamine (CKA-1306) against calcium/calmodulin-dependent protein kinase IH Sakaguchi, H Yokokura, O Terada, et al.Pageof 447